Akebia Therapeutics
Clinical trials sponsored by Akebia Therapeutics, explained in plain language.
-
Kidney anemia pill for kids: study pulled before start
Disease control TerminatedThis study planned to test a daily pill called vadadustat for anemia in children with chronic kidney disease. Anemia means not enough healthy red blood cells, which can cause tiredness. The goal was to see if the drug safely raises hemoglobin levels. However, the study was withdr…
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated May 17, 2026 10:42 UTC
-
New pill may help dialysis patients fight anemia without needles
Disease control OngoingThis study tests a new drug called vadadustat for anemia in people with end-stage kidney disease who are on dialysis. About 350 adults will take either vadadustat three times a week or a standard injected ESA. The goal is to see if the new drug keeps hemoglobin levels in a health…
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Kidney anemia pill for kids study pulled before start
Disease control TerminatedThis study aimed to test a daily pill called vadadustat for treating anemia in children with chronic kidney disease. It planned to switch kids from standard injections to this oral medicine and check if their red blood cell levels stayed healthy. However, the study was withdrawn …
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated May 13, 2026 15:59 UTC